March 27, 2015
The Lancet Neurology, together with IDIBAPS researchers, has presented in Barcelona recent advances in autoimmune encephalitis
Today concludes the international conference organized by the prestigious journal Lancet Neurology in Barcelona to discuss the latest scientific and clinical studies in the field of autoimmune disorders affecting the central nervous system. In the conference have participated, among others, Dr. Josep Dalmau, ICREA researcher at IDIBAPS, where leads the Autoimmune Pathogenesis of Neuronal Diseases group, and professor of Neurology at the University of Pennsylvania; Dr. Francesc Graus, head of the Neurology Department at Hospital Clínic; and Susannah Cahalan, an american journalist, author of the best-seller Brain on Fire, in which she explains her experience until she was diagnosed with an autoimmune encephalitis, a disease little known until then.
March 26, 2015
The Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) hosted on 13 and 14 March the second training course of the AstraZeneca Chair in Diabetes Innovation. With the main objective of conveying the interest and value of research to understand, prevent and cure diabetes and its complications, this second course has mainly been focused on three issues: the benefits of exercise in people with diabetes; the use of nanovaccines in the field of autoimmune diseases and diabetes; and new prototypes of artificial mini-pancreas.
March 16, 2015
The Lilly Foundation has awarded the 2015 Biomedical Research Awards in the categories of preclinical and clinical research, respectively, to Dr. Miguel Beato, researcher, founder and first director of the Centre for Genomic Regultaion (CRG), and Dr. Elías Campo, Research Director of Hospital Clínic and Fundació Clínic and head of the Human and Experimental Functional Oncomorphology IDIBAPS Group. These awards recognize excellence scientific career of researchers who have contributed to a high quality Biomedical research in Spain.
March 5, 2015
Dr. Joan Albert Barberà coordinates the Corporate Research Program (CRP) on pulmonary hypertension that has launched the Networked Biomedical Research Center for Respiratory Diseases (CIBERES). The program's main goal is to identify markers that will help in the diagnosis and to find new therapeutic targets for this disease. Dr. Barbera is pneumologist at Hospital Clínic, leader of the IDIBAPS team Pathophysiological Mechanisms of Respiratory Ilnesses and researcher at CIBERES.
March 4, 2015
Dr. Joan Rodés, former director of the Hospital Clínic and IDIBAPS, emeritus professor at the University of Barcelona and coordinator of the new National Strategic Plan for hepatitis C, was one of the three people awarded with the Gold Medal of the Generalitat of Catalonia. Dr. Rodés receives this recognition for the work developed over 40 years as a physician and researcher on liver diseases.